Blood Biomarkers to Predict the Prognosis of a Stroke Patient Undergoing Mechanical Thrombectomy

Last updated: June 20, 2024
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Overall Status: Active - Recruiting

Phase

N/A

Condition

Thrombosis

Stroke

Blood Clots

Treatment

Large Vessel Occlusion Biomarkers Test

Clinical Study ID

NCT06467396
TROMBOPOCT
  • Ages > 18
  • All Genders

Study Summary

The goal of this observational study is to evaluate the accuracy of a panel of blood biomarkers and clinical variables in predicting the prognosis of stroke patients treated by mechanical thrombectomy, specifically to predict futile recanalization and mortality.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients > 18 years old.

  • Patient in whom a mechanical thrombectomy is performed.

Exclusion

Exclusion Criteria:

  • Impossibility of getting a blood sample.

  • Impossibility of performing the test (Invalid results)

  • Refusal to provide the informed consent by the patient/relative.

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Large Vessel Occlusion Biomarkers Test
Phase:
Study Start date:
April 09, 2024
Estimated Completion Date:
July 31, 2025

Study Description

Stroke is the leading cause of long-term disability and the second most common cause of death worldwide, accounting for around 6.7 million deaths each year. The burden of stroke due to illness, disability and early death is set to double within the next 15 years due to an ageing population. The socio-economical cost of the stroke is very high, being around 45 million euros per year in Europe. Although mechanical thrombectomy is the most effective treatment for stroke patients with large vessel occlusions still a large percentage of patients, around 50%, do not recover despite a successful recanalization (the so called "futile recanalization"). Therefore, to anticipate the prognosis of patients treated with mechanical thrombectomy would be clinically relevant and very informative.

This observational study evaluates the precision of a rapid test of blood biomarkers in the prognosis of stroke patients treated by mechanical thrombectomy. For that, the investigators will recruit a cohort of 400 consecutive patients treated by thrombectomy. Using a multiplex POC for the biomarker measurement and an APP in combination with clinical data, the potential of biomarkers to predict the prognosis of a patient will be determined.

Connect with a study center

  • Hospital Universitario Reina Sofía

    Córdoba,
    Spain

    Active - Recruiting

  • Hospital Universitario Virgen Rocío

    Sevilla,
    Spain

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.